Delivery Order SPE2DB22D9367-SPE2DB23FSV89
Award Date 1/9/23
Potential Completion Date 1/31/23
Potential Value $116K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide KEYTRUDA 100 MG/4 ML VIAL 4ML. The order has a potential value of $80,285.70 and a completion date of February 8, 2024. DMS Pharmaceutical Group Inc. holds an indefinite delivery contract with DLA to supply a variety of pharmaceutical and medical products to support military treatment facilities globally. This specific order is delivered under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product KEYTRUDA 100 MG/4 ML VIAL 4ML. The contract has a completion date of January 30, 2024 and a potential value of $24,065.52. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles with DLA to supply a variety of prescription...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Keytruda 100 mg/4 ml vials. The award, valued at $51,829.00, is part of a larger indefinite delivery contract (DLA contract 4600082013 under the SPE2DB program) with DMS Pharmaceutical Group that has a total potential value up to $4,999,999 through 2025. This contract vehicle enables the DLA to issue delivery orders...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $48,131.04 contract is to provide Keytruda 100 mg/4 ml vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,563,469,465 units of the pharmaceutical product KEYTRUDA 100 MG/4 ML VIAL 4ML. The contract has a completion date of February 12, 2024 and a potential value of $80,218.40. This delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA to provide various pharmaceutical and medical supplies...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,556,021,794 units of the pharmaceutical product KEYTRUDA 100 MG/4 ML VIAL 4ML. The potential value of this delivery order is $111,615.60, with a completion date of February 1, 2022. DMS Pharmaceutical Group is an experienced federal contractor that holds multiple contracts and indefinite delivery vehicles with DLA to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Keytruda 100 mg/4 ml vials. The contract has a potential value of $40,109.20 and a completion date of March 11, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with DLA, which enables the agency to order a broad range of pharmaceutical products to support...
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,559,396,275 units of the pharmaceutical item KEYTRUDA 100 MG/4 ML VIAL 4ML. The $117,514.94 delivery order has a completion date of January 5, 2023. DMS Pharmaceutical Group is an experienced federal contractor that holds various contracts and indefinite delivery vehicles with the Defense Logistics Agency to supply a wide...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a $218,175.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business and leading pharmaceutical wholesaler. The contract is for the delivery of KEYTRUDA 100 MG/4 ML VIAL 4ML, with a period of performance through January 30, 2024. This delivery order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA Troop Support Medical, which has a potential...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide 4,564,751,606 units of Keytruda 100 mg/4 mL vial. The firm-fixed-price contract, valued at $80,218.40, runs through June 14, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which was awarded by the DLA to fulfill the recurring...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB23FSV89Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide KEYTRUDA 100 MG/4 ML VIAL 4ML. The $116,257.80 contract has a period of performance through January 31, 2023 and is not set-aside. DMS Pharmaceutical Group holds multiple contracts and indefinite delivery vehicles with DLA Troop Support Medical to supply a variety of pharmaceutical and medical products in support of military treatment facilities worldwide.
Generated 3/24/24, 9:22 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $116.3k | 1/9/23 |